Free Trial
TSE:BCT

BriaCell Therapeutics (BCT) Stock Price, News & Analysis

C$1.07
-0.03 (-2.73%)
(As of 11/4/2024 05:19 PM ET)

About BriaCell Therapeutics Stock (TSE:BCT)

Key Stats

Today's Range
C$1.06
C$1.09
50-Day Range
C$0.65
C$1.63
52-Week Range
C$0.64
C$8.00
Volume
4,903 shs
Average Volume
23,074 shs
Market Capitalization
C$38.35 million
P/E Ratio
N/A
Dividend Yield
13.70%
Price Target
N/A
Consensus Rating
N/A

Company Overview

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Receive BCT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

BCT Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

BCT Stock Analysis - Frequently Asked Questions

BriaCell Therapeutics' stock was trading at C$7.80 on January 1st, 2024. Since then, BCT shares have decreased by 86.3% and is now trading at C$1.07.
View the best growth stocks for 2024 here
.

BriaCell Therapeutics Corp. (TSE:BCT) posted its quarterly earnings results on Monday, October, 28th. The company reported ($0.10) EPS for the quarter, beating the consensus estimate of ($0.70) by $0.60.

Shares of BCT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Company Calendar

Last Earnings
10/28/2024
Today
11/04/2024
Next Earnings (Estimated)
12/12/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
16
Year Founded
N/A

Profitability

Net Income
C$-6,000,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
C($0.37) per share

Miscellaneous

Free Float
N/A
Market Cap
C$38.35 million
Optionable
Not Optionable
Beta
1.83
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (TSE:BCT) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners